Theramex Leverages AlphaSense to Fuel Global Growth and Expansion into New Territories

The Challenge

  • Existing market research workflows required significant manual screening and monitoring of multiple news sources to derive relevant information
  • Reliance on fragmented sources like ad-hoc industry reports, subject matter experts (SMEs), and Google search spurred inefficiencies and hindered ability to access a well-rounded view into trends

The Solution

  • Efficiencies gained through having one unified source of information
  • Multi-dimensional findings increased the quality of research and enabled the team to form more structured, confident recommendations
  • Research cost and time savings leveraging a consolidated expert transcript library for competitive intelligence

“The most significant impact has been twofold: we’ve become more efficient in our processes, and the quality of our research output has noticeably improved thanks to AlphaSense.”

– Paula Kowalska, Sr. Manager, Corporate Development

The Company

Theramex is a leading pharmaceutical company solely committed to supporting the health needs of women through every stage of life. The company offers a comprehensive range of treatments across fertility, contraception, menopause, uterine health and osteoporosis. Focusing on empowering women of all ages, Theramex delivers innovative, patient-centric solutions in more than 50 countries across the globe and continues to expand its footprint. Its goal is to become a “true global leader” in the women’s healthcare space.

The Challenge: Creating Efficiencies to Drive Expansion

Theramex’s corporate development team previously relied on a mix of industry reports, SMEs, and manual internet searches for market research. “This fragmented approach was time-intensive and lacked the agility required to quickly respond to emerging opportunities,” according to Paula Kowalska, a Senior Manager of Corporate Development at the firm. 

As Theramex continues to expand—having entered the Mexican market and launched two innovative products in Osteoporosis and Uterine Health—the need for a unified intelligence platform became clear. To support its growth ambitions, broaden therapy areas, and address patient needs globally, the team sought a solution to enhance decision-making and provide a comprehensive view of market dynamics. They intend to expand into the United States and / or expand into adjacent therapeutic areas, a transformative undertaking that will revolutionize their brand’s reach and empower them to serve a vastly broader audience.

“Our research processes were manual and time-consuming, making it difficult to access a holistic view of industry trends and opportunities. We needed a solution to elevate our efficiency and the quality of our insights.”

Paula Kowalska

Streamlined Intelligence that Drives Confident Decisions

Leveraging a unified source of trusted market intelligence is critical for Theramex as it expands its therapeutic and geographic reach. The team focuses on sourcing and executing licensing and M&A opportunities in diseases that affect women to expand Theramex portfolio and reach. AlphaSense emerged as a pivotal tool for Theramex, consolidating multiple intelligence streams into one platform. The advanced search and alert features allowed the team to stay ahead of industry developments, competitor activity, and emerging trends, enabling faster, more confident decisions.

“The AlphaSense platform’s advanced search and alert features keep us updated on relevant developments in real time. This capability enables us to respond with agility and confidence to opportunities in our field.”

– Paula Kowalska

Recently, the Theramex team enhanced their workflow with AlphaSense’s Generative Search, enabling them to quickly synthesize information and gain instant insights from the extensive AlphaSense content library, complete with references and citations for deeper exploration. According to Kowalska, accessing the references makes her more confident in her decision-making and allows her to dive deeper into these sources directly.

“At Theramex, we’re always encouraged to find ways AI can make our work more efficient, and AlphaSense’s Generative Search is a great example of that. It has been instrumental in evaluating assets and companies efficiently”

-Paula Kowalska

To best guide their strategic recommendations, Kowalska noted that the Expert Transcript Library has been an invaluable resource to the Theramex team to guide their commercial product evaluations. Understanding the perspective of prescribing physicians has enabled the team to craft well-informed recommendations, aligned with market needs, ultimately reducing the cost of research and time required to make sound decisions.

Looking to the Future

With a clear goal of expanding their global reach, the Theramex team remains sharply focused on executing deals and uncovering opportunities in the women’s health space. By leveraging AI and the cutting-edge generative AI features within AlphaSense, they are equipping themselves with the actionable intelligence and insights needed to drive forward their vision of ultimate market leadership in the women’s healthcare space.

Get started today

The world’s leading corporations and financial institutions—including a majority of the S&P 500, over 85% of the S&P 100, and 75% of the top asset management firms—trust AlphaSense for smarter, faster decisions.

Start my free trial
alpha sense trial